ORAMED PHARMACEUTICALS INC. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.48 USD/shares, a 500% decline year-over-year.
  • Oramed Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 0.11 USD/shares, a 8.33% decline year-over-year.
  • Oramed Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was 0.14 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0.11 $0 $0 -500% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $0.51 $0.22 +$0.25 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $0.26 $0.04 +$0.12 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0.14 $0.33 +$0.02 +6.45% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $0.12 $0 $0 -144% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0.38 $0 $0 -111% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $0.68 $0 $0 -130% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.03 $0.31 Sep 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 $0.18 $0 -14.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0.27 +$0.15 +125% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0.27 +$0.07 +35% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0.21 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0.12 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $0.20 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.